Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer.

Sandra M. Swain, Richard Sorace, Caroline S. Bagley, +5

PubMed

Surgical OncologyBreast OncologyHormonal SynchronizationPathologyTumor Biology +14

103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma

Michael Dattoli, Kent E. Wallner, Richard Sorace, +11

International Journal of Radiation Oncology*Biology*Physics

UrologyRadiation TherapyMedicineBrachytherapyHigh-risk Prostatic Carcinoma +5

Long‐term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high‐risk features

Michael Dattoli, Kent E. Wallner, Lawrence D. True, +2

Cancer

Long‐term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma

Michael Dattoli, Kent E. Wallner, Lawrence D. True, +2

Cancer

Cancer ManagementHigher RiskRadiation MedicineOncologyGenitourinary Cancer +15

Prognostic role of serum prostatic acid phosphatase for 103Pd-based radiation for prostatic carcinoma

Michael Dattoli, Kent E. Wallner, Lawrence D. True, +10

International Journal of Radiation Oncology*Biology*Physics

Tumor BiologyUrologyRadiation TherapyPrognostic RoleMedicine +9

The management of nonmetastatic locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery

Richard Sorace, Caroline S. Bagley, Allen S. Lichter, +4

World Journal of Surgery

Long-Term Outcomes for Patients with Prostate Cancer Having Intermediate and High-Risk Disease, Treated with Combination External Beam Irradiation and Brachytherapy

Michael Dattoli, Kent E. Wallner, Lawrence D. True, +3

Journal of Oncology

Surgical OncologyUrologyRadiation TherapyMedicineCancer Management +12

Prostatic Acid Phosphatase Adversely Affects Cause-Specific Survival in Patients with Intermediate to High-Risk Prostate Cancer Treated with Brachytherapy

Lekun Fang, Michael Dattoli, Al V. Taira, +3

Urology

UrologyGenitourinary CancerMedicineBrachytherapyCause-specific Survival +3

Long-Term Prostate Cancer Control Using Palladium-103 Brachytherapy and External Beam Radiotherapy in Patients with a High Likelihood of Extracapsular Cancer Extension

Michael Dattoli, Kent E. Wallner, Lawrence D. True, +2

Urology

Surgical OncologyUrologyRadiation TherapyMedicineBrachytherapy +5

1056 Conformal brachytherapy boost to external beam irradiation for clinically localized high risk prostate cancer

Michael Dattoli, Stuart Wasserman, John M. Koval, +3

International Journal of Radiation Oncology*Biology*Physics

Radiation MedicineConformal Brachytherapy BoostHealth SciencesRadiation TherapyMedicine +7